Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin

Technology in Cancer Research and Treatment

Volumn 12, Issue 6, 2013, Pages 525-535

  Wang, Yao Dong ^a   Li, Sheng Jiao ^a   Liao, Jian Xing ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Chemosensitivity; Cisplatin; Glucose transporter 1; Head and neck squamous cell cancer; Hypoxia; Normoxia

Indexed keywords

CISPLATIN; GLUCOSE TRANSPORTER 1; MESSENGER RNA; OXYGEN; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE SILENCING; GLUCOSE TRANSPORT; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GROWTH; WESTERN BLOTTING;

ANTIBODIES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HEAD AND NECK NEOPLASMS; HUMANS; RNA, SMALL INTERFERING;

EID: 84885017673     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500343     Document Type: Article

References (38)

1. Mehanna, H., Paleri, V., West, C.M., Nutting, C. Head and neck cancer-Part 1: Epidemiology, presentation, and prevention. BMJ 341, c4684 (2010). DOI: 10.1136/bmj.c4684
2. Mehanna, H., West, C.M., Nutting, C., Paleri, V. Head and neck cancer-Part 2: treatment and prognostic factors. BMJ 341, c4690 (2010). DOI: 10.1136/bmj.c4690
3. Mueckler, M., Caruso, C., Baldwin, S.A., Panico, M., Blench, I., Morris, H.R., Allard, W.J., Lienhard, G.E., Lodish, H.F. Sequence and structure of a human glucose transporter. Science 229, 941-5 (1985). DOI: 10.1126/science.3839598
4. Olson, A.L., Pessin, J.E. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 16, 235-56 (1996). DOI: 10.1146/annurev.nu.16. 070196.001315
5. Oliver, R.J., Woodwards, R.T., Sloan, P., Thakker, N.S., Stratford, I.J., Airley, R.E. Prognostic value of facilitative glucose transporter GLUT1 in oral squamous cell carcinomas treated by surgical resection: results of EORTC translational research Fund studies. Eur J Cancer 40, 503-507 (2004). DOI: 10.1016/j.ejca.2003.10.024
6. Li, S.J., Guo, W., Ren, G.X., Huang, G., Chen, T., Song, S.L. Expression of GLUT1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg 46, 180-186 (2008). DOI: 10.1016/j.bjoms.2007.11.003
7. Kunkel, M., Moergel, M., Stockinger, M., Jeong, J.H., Fritz, G., Lehr, H.A., Whiteside, T.L. Overexpression of GLUT1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. Oral Oncol 43, 796-803 (2007). DOI: 10.1016/j.oraloncology.2006.10.009
8. Kim, H.H., Joo, H., Kim, T., Kim, E., Park, S.-J., Kyoung Park, J., Kim, H.J. The mitochondrial warburg effect: a cancer enigma. Interdisciplinary Bio Central 1, 1-7 (2009). DOI: 10.4051/ ibc.2009.2.0007
9. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009). DOI: 10.1126/science.1160809
10. Lu, J., Sharma, L.K., Bai, Y. Implications of mitochondrial DNA mutations and mito-chondrial dysfunction in tumorigenesis. Cell Res 19, 802-815 (2009). DOI: 10.1038/cr.2009.69
11. Cao, X., Fang, L., Gibbs, S., Huang, Y., Dai, Z., Wen, P., Zheng, X., Sadee, W., Sun, D. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol 59, 495-505 (2007). DOI: 10.1007/s00280-006-0291-9
12. Bubnovskaya, L., Mikhailenko, V., Kovelskaya, A., Osinsky, S. Bioenergetic status and hypoxia in Lewis lung carcinoma assessed by 31P NMR spectroscopy: correlation with tumor progression. Exp Oncol 29, 207-211 (2007). [DOI not found]
13. Supiot, S., Hill, R.P., Bristow, R.G. Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53. Mol Cancer Ther 7, 993-999 (2008). DOI: 10.1158/1535-7163
14. Roh, J.L., Cho, K.J., Kwon, G.Y., Ryu, C.H., Chang, H.W., Choi, S.H., Nam, S.Y., Kim, S.Y. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol 45, 63-68 (2009). DOI: 10.1016/j.oraloncology.2008.03.017
15. Kunkel, M., Förster, G.J., Reichert, T.E., Jeong, J.H., Benz, P., Bartenstein, P., Wagner, W., Whiteside, T.L. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer 98, 2257-2265 (2003). DOI: 10.1002/cncr.11763
16. Evans, A., Bates, V., Troy, H., Hewitt, S., Holbeck, S., Chung, Y.L., Phillips, R., Stubbs, M., Griffiths, J., Airley, R. GLUT1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother Pharmacol 61, 377-393 (2008). DOI:10.1007/s00280-007-0480-1
17. Chung, F.Y., Huang, M.Y., Yeh, C.S., Chang, H.J., Cheng, T.L., Yen, L.C., Wang, J.Y., Lin, S.R. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer 9, 241-252 (2009). DOI: 10.1186/1471-2407-9-241
18. Brophy, S., Sheehan, K.M., McNamara, D.A., Deasy, J., Bouchier-Hayes, D.J., Kay, E.W. GLUT1 expression and response to chemoradiotherapy in rectal cancer. Int J Cancer 125, 2778-2782 (2009). DOI: 10.1002/ijc.24693
19. Sandulache, V.C., Skinner, H.D., Ow, T.J., Zhang, A., Xia, X., Luchak, J.M., Wong, L.J., Pickering, C.R., Zhou, G., Myers, J.N. Individualizing Antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status. Cancer 118, 711-721 (2012). DOI: 10.1002/cncr.26321
20. Brown, R.S., Wahl, R.L. Overexpression of GLUT1 glucose transporter in human breast cancer. Cancer 72, 2979-2985 (1993). DOI: 10.1002/1097-0142(19931115)72:10<2979 AID-CNCR2820721020>3.0.CO;2-X
21. Ameri, K., Luong, R., Zhang, H., Powell, A.A., Montgomery, K.D., Espinosa, I., Bouley, D.M., Harris, A.L., Jeffrey, S.S. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer 102, 561-569 (2010). DOI: 10.1038/sj.bjc.6605491
22. Liu, L., Ning, X., Sun, L., Zhang, H., Shi, Y., Guo, C., Han, S., Liu, J., Sun, S., Han, Z., Wu, K., Fan, D. Hypoxia-inducible factor-1a contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99, 121-128 (2008). DOI: 10.1111/j.1349-7006.2007.00643.x
23. Motrescu, E.R., Otto, A.M., Brischwein, M., Zahler, S., Wolf, B. Dynamic analysis of metabolic effects of chloroacetaldehyde and cytochalasin B on tumor cells using bioelectronic sensor chips. J Cancer Res Clin Oncol 131, 683-691 (2005). DOI: 10.1007/s00432-005-0015-2
24. Liang, X.J., Yin, J.J., Taylor, B., Winkovitch, S.M., Garfield, S.H., Shen, D.W., Gottesman, M.M., Aszalos, A. Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines. Cancer Chemother Pharmacol 62, 977-984 (2008). DOI: 10.1007/s00280-008-0687-9
25. Plagemann, P.G., Zylka, J.H., Erbe, J., Estensen, R.D. Membrane effects of cytochalasin B. Competitive inhibition of facilitated diffusion processes in rat hepatoma cells and other cell lines and effect on formation of functional transport sites. J Membr Biol 23, 77-90 (1975). DOI: 10.1007/BF01870245
26. Carruthers, A. Facilitated diffusion of glucose. Physiol Rev 70, 1135-1176 (1990). [DOI not found]
27. Uldry, M., Thorens, B. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447, 480-9 (2004). DOI: 10.1007/s00424-003-1085-0
28. Oda, S., Oda, T., Nishi, K., Takabuchi, S., Wakamatsu, T., Tanaka, T., Adachi, T., Fukuda, K., Semenza, G.L., Hirota, K. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One 3, e2215 (2008) DOI: 10.1371/journal.pone.0002215
29. Brown, J.M. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1, 453-458 (2002). DOI: 10.4161/cbt.1.5.157
30. Wouters, B.G., Weppler, S.A., Koritzinsky, M., Landuyt, W., Nuyts, S., Theys, J., Chiu, R.K., Lambin, P. Hypoxia as a target for combined modality treatments. Eur J Cancer 38, 240-257 (2002). DOI: 10.1016/S0959-8049(01)00361-6
31. Airley, R.E., Phillips, R.M., Evans, A.E., Double, J., Burger, A.M., Feibig, H.H., West, C.M., Stratford, I.J. Hypoxia-regulated glucose transporter Glut1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. Int J Oncol 26, 1477-1484 (2005). [DOI not found]
32. Smith, T.A., Sharma, R.I., Wang, W.G., Welch, A.E., Schweiger, L.F., Collie-Duguid, E.S. Decreased [18F]fluoro-2-deoxy-D-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro. J Nucl Med Biol 34, 955-960 (2007). DOI: 10.1016/j.nucmedbio.2007.07.007
33. Höckel, M., Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266-276 (2001). DOI: 10.1093/jnci/93.4.266
34. Holmquist, L., Jögi, A., Påhlman, S. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int J Cancer 116, 218-225 (2005). DOI: 10.1002/ijc.21024
35. Heddleston, J.M., Li, Z., Lathia, J.D., Bao, S., Hjelmeland, A.B., Rich, J.N. Hypoxia inducible factors in cancer stem cells. Br J Cancer 102, 789-795 (2010). DOI: 10.1038/sj.bjc.6605551
36. Cairns, R.A., Kalliomaki, T., Hill, R.P. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61, 8903-8908 (2001). [DOI not found]
37. Egawa-Takata, T., Endo, H., Fujita, M., Ueda, Y., Miyatake, T., Okuyama, H., Yoshino, K., Kamiura, S., Enomoto, T., Kimura, T., Inoue, M. Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer. Cancer Sci 101, 2171-2178 (2010). DOI: 10.1111/j.1349-7006.2010.01670.x
38. Brophy, S., Sheehan, K.M., McNamara, D.A., Deasy, J., Bouchier-Hayes, D.J., Kay, E.W. GLUT1 expression and response to chemoradiotherapy in rectal cancer. Int J Cancer 125, 2778-2782 (2009). DOI: 10.1002/ijc.24693